Project Grant R44DK139895
Award Date
9/20/24
Completion Date
6/30/26
Dollars Obligated
$3.7M
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
Winston-Salem, NC 27101, USA
Similar Awards
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $1,930,758 Project Grant to Sylvatica Biotech Inc. under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant supports the development of "Enhanced Supercooling" techniques to enable extended non-frozen preservation of clinical-scale donor livers for up to 72 hours. This innovation aims to significantly increase the viable storage time for donated...
The federal Project Grant award R01DK140070, in the amount of $700,619, was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research (CFDA 93.847) program. The goal of this 4-year award is to study and control rhythmic nephron induction for kidney replacement tissues. The research aims to gain temporal control over rhythmic nephron formation in human induced pluripotent stem cell-derived kidney...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports the development of a novel, biodegradable and elastic vascular graft for hemodialysis access. The $298,371 award will enable the awardee, Anova Biomedical, Inc., to refine manufacturing techniques for the "DeNovo1" graft and evaluate its performance in a sheep model to mimic...
This federal Project Grant award of $344,632 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) will support research to evaluate the impact of recent changes to the kidney allocation system in the United States. The research aims to: (1) assess whether the supply of organs is equitably distributed among U.S. transplant centers under the new 250-nautical-mile kidney...
The federal Project Grant award R01DK141374, totaling $545,999.00, was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant aims to determine the mechanisms by which two key proteins, AXL and AIF-1, regulate the function of monocytes and macrophages in kidney transplant recipients. Specifically, the project will investigate how AXL influences early...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $725,420 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to develop an optimized allysine-targeted positron emission tomography (PET) probe and validate it in animal models and human renal biopsy samples. The goal is to establish a non-invasive...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $238,184 Project Grant (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) to the University of Delaware to develop an easy-to-use 3D microphysiological system (MPS) that can spatially pattern the extracellular matrix, stromal cells, and soluble factors to recapitulate the developing nephron. The goal is to provide researchers without MPS expertise a tool to investigate the role and...
The federal Project Grant award R43DK139879, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), is funding the development of a proteomic assay for monitoring transplanted cells and tissues. The $175,964 award to Hepatx Corporation will enable the creation of a simple blood test to measure the success of hepatocyte (liver cell) transplantation in human patients,...
This $704,672 Phase I SBIR project grant awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) aims to develop an implantable device to improve vascular access for hemodialysis patients. The project will use state-of-the-art materials and engineering techniques to refine the manufacturability and operational parameters of the device, which features a 3D-printed...
This is a Project Grant awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), in the amount of $548,830.00. The grant was awarded to Nephsmart LLC, a for-profit limited liability company located in Little Rock, AR, to develop and test a device that can predict the future risk of severe acute kidney injury (AKI). The project aims to build a point-of-care test that can...